These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2978746)

  • 21. Insulin treatment reduces the increased serum and lung angiotensin converting enzyme activity in streptozotocin-induced diabetic rats.
    Erman A; Chen-Gal B; David I; Giler S; Boner G; van Dijk DJ
    Scand J Clin Lab Invest; 1998 Feb; 58(1):81-7. PubMed ID: 9516660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of glomerular filtration and plasma flow in experimental diabetic rats.
    Michels LD; Davidman M; Keane WF
    J Lab Clin Med; 1981 Dec; 98(6):869-85. PubMed ID: 7031154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-peptide replacement improves weight gain and renal function in diabetic rats.
    Rebsomen L; Pitel S; Boubred F; Buffat C; Feuerstein JM; Raccah D; Vague P; Tsimaratos M
    Diabetes Metab; 2006 Jun; 32(3):223-8. PubMed ID: 16799398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of aspirin on experimental diabetic nephropathy.
    Moel DI; Safirstein RL; McEvoy RC; Hsueh W
    J Lab Clin Med; 1987 Sep; 110(3):300-7. PubMed ID: 3475395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of glomerular hyperfiltration by dopamine D(2)-like receptor blockade in experimental diabetes mellitus.
    Luippold G; Beilharz M; Mühlbauer B
    Nephrol Dial Transplant; 2001 Jul; 16(7):1350-6. PubMed ID: 11427624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glomerular abnormalities in long-term experimental diabetes. Role of hemodynamic and nonhemodynamic factors and effects of antihypertensive therapy.
    Fujihara CK; Padilha RM; Zatz R
    Diabetes; 1992 Mar; 41(3):286-93. PubMed ID: 1551488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regression of renal hypertrophy and elevated renal Na+,K+-ATPase activity after insulin treatment in streptozotocin-diabetic rats.
    Ku DD; Roberts RB; Sellers BM; Meezan E
    Endocrinology; 1987 May; 120(5):2166-73. PubMed ID: 3032576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal function in streptozotocin-diabetic rats.
    Jensen PK; Christiansen JS; Steven K; Parving HH
    Diabetologia; 1981 Oct; 21(4):409-14. PubMed ID: 7286501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes.
    Allen TJ; Waldron MJ; Casley D; Jerums G; Cooper ME
    Diabetes; 1997 Jan; 46(1):19-24. PubMed ID: 8971091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated plasma atrial natriuretic peptide levels in diabetic rats. Potential mediator of hyperfiltration.
    Ortola FV; Ballermann BJ; Anderson S; Mendez RE; Brenner BM
    J Clin Invest; 1987 Sep; 80(3):670-4. PubMed ID: 2957390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disparate effects of castration on renal structure and function in the streptozotocin diabetic rat.
    Bach LA; Cooper ME; Vranes D; Allen TJ; Rumble J; Jerums G
    Diabetes Res; 1994; 27(1):27-38. PubMed ID: 7648794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular and renal characteristics, and responses to acute volume expansion of a rat model of diabetic pregnancy.
    Tang D; Yu T; Khraibi AA
    Life Sci; 2004 Apr; 74(23):2909-18. PubMed ID: 15050428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentration(s) of atrial natriuretic hormone in the plasma of rats with streptozotocin-induced diabetes mellitus.
    Hebden RA; McNeill JH
    Life Sci; 1988; 42(18):1789-95. PubMed ID: 2966273
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of glomerular hyperfiltration and renal hypertrophy by blood glucose normalization in diabetic rats.
    Stackhouse S; Miller PL; Park SK; Meyer TW
    Diabetes; 1990 Aug; 39(8):989-95. PubMed ID: 2373266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of diabetes and hypertension on glomerular transforming growth factor-beta receptor expression.
    Kang MJ; Ingram A; Ly H; Thai K; Scholey JW
    Kidney Int; 2000 Oct; 58(4):1677-85. PubMed ID: 11012901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C-peptide normalizes glomerular filtration rate in hyperfiltrating conscious diabetic rats.
    Stridh S; Sällström J; Fridén M; Hansell P; Nordquist L; Palm F
    Adv Exp Med Biol; 2009; 645():219-25. PubMed ID: 19227475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glomerular filtration rate in early experimental diabetes.
    O'Brien RC; Allen TJ; Cooper ME; Bach L; Jerums G
    J Diabet Complications; 1988; 2(1):8-11. PubMed ID: 2968359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transient glomerular hyperfiltration in the streptozotocin-diabetic Wistar Furth rat.
    Palm F; Liss P; Fasching A; Hansell P; Carlsson PO
    Ups J Med Sci; 2001; 106(3):175-82. PubMed ID: 12166509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.
    Tikkanen I; Tikkanen T; Cao Z; Allen TJ; Davis BJ; Lassila M; Casley D; Johnston CI; Burrell LM; Cooper ME
    J Hypertens; 2002 Apr; 20(4):707-14. PubMed ID: 11910307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lovastatin preserves renal function in experimental diabetes.
    Inman SR; Stowe NT; Cressman MD; Brouhard BH; Nally JV; Satoh S; Satodate R; Vidt DG
    Am J Med Sci; 1999 Apr; 317(4):215-21. PubMed ID: 10210355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.